↓ Skip to main content

Antiangiogenic therapy for high-grade glioma

Overview of attention for article published in Cochrane database of systematic reviews, September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet
twitter
4 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
137 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antiangiogenic therapy for high-grade glioma
Published in
Cochrane database of systematic reviews, September 2014
DOI 10.1002/14651858.cd008218.pub3
Pubmed ID
Authors

Mustafa Khasraw, Malaka S Ameratunga, Robin Grant, Helen Wheeler, Nick Pavlakis

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Estonia 1 <1%
Ecuador 1 <1%
Brazil 1 <1%
Unknown 133 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 28 20%
Student > Master 24 18%
Researcher 16 12%
Student > Doctoral Student 13 9%
Student > Bachelor 12 9%
Other 29 21%
Unknown 15 11%
Readers by discipline Count As %
Medicine and Dentistry 70 51%
Agricultural and Biological Sciences 14 10%
Biochemistry, Genetics and Molecular Biology 9 7%
Nursing and Health Professions 5 4%
Engineering 4 3%
Other 15 11%
Unknown 20 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2019.
All research outputs
#1,139,159
of 14,574,577 outputs
Outputs from Cochrane database of systematic reviews
#3,276
of 11,017 outputs
Outputs of similar age
#18,707
of 208,012 outputs
Outputs of similar age from Cochrane database of systematic reviews
#64
of 218 outputs
Altmetric has tracked 14,574,577 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,017 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,012 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.